Generics [UK] Ltd t/a Mylan v Yeda Research and Development Company Ltd and Another

JurisdictionEngland & Wales
JudgeLord Justice Floyd,Lord Justice Kitchin,Lord Justice Moses,Sir Robin Jacob,Lord Justice Etherton,Lord Justice Ward
Judgment Date29 July 2013
Neutral Citation[2013] EWCA Civ 925,[2012] EWCA Civ 726
Docket NumberCase No: A3/2012/2136,Case No: A3/2011/3284
CourtCourt of Appeal (Civil Division)
Date29 July 2013
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
31 cases
  • Gilead Sciences Inc. (a company registered in the US State of Delaware) v Nucana Plc
    • United Kingdom
    • Chancery Division (Patents Court)
    • 21 March 2023
    ...I accept this too. I dealt with it in Sandoz at [63] – [69], primarily by reference to what Floyd LJ said in Generics v Yeda [2013] EWCA Civ 925 at [64]–[65]. iii) A technical contribution must be of some, even if low, real significance. Disclosing a uselessly low degree of activity as a c......
  • Re Boehringer Ingelheim Pharma GmbH & Company Kg & Patents Acts
    • Ireland
    • High Court
    • 26 July 2017
    ...in the courts of the neighbouring jurisdiction. (See, e.g., Generics (UK) Ltd (t/a Mylan) v. Yeda Research & Development Co. Ltd [2013] EWCA Civ. 925 and Idenix Pharmaceuticals Inc. v. Gilead Sciences Inc. [2016] EWCA Civ. 1089). It applies where a development may not be obvious but where......
  • Pfizer Ltd v Glaxosmithkline Biologicals S.A (a company incorporated under the laws of Belgium)
    • United Kingdom
    • Chancery Division (Patents Court)
    • 7 October 2024
    ...by Court of Appeal in Sandoz & Teva v BMS [2023] EWCA Civ 472, citing the explanation given by Floyd LJ in Generics v Yeda [2013] EWCA Civ 925 at [39] as part of their consideration of the case law. “39. As with any consideration of obviousness, the technical results or effects must be......
  • Teva Pharmaceutical Industries Ltd v Novartis AG
    • United Kingdom
    • Chancery Division (Patents Court)
    • 10 November 2022
    ...will not be found invalid as an arbitrary selection, whether for lack of inventive step, see for example Generics (UK) Ltd v Yeda Research & Development Co Ltd [2013] EWCA Civ 925 or for insufficiency, see for example Idenix Pharmaceuticals Inc v Gilead Sciences Inc [2016] EWCA Civ 1089. Ho......
  • Request a trial to view additional results
5 firm's commentaries
  • IP Bulletin - Autumn 2012
    • United Kingdom
    • Mondaq United Kingdom
    • 5 November 2012
    ...advisers or patent attorneys). Generics (UK) Ltd v Yeda Research & Development Co Ltd & Teva Pharmaceutical Industries Ltd [2012] EWCA Civ 726 http://www.bailii.org/ew/cases/EWCA/Civ/2012/726.html Generics (UK) Ltd ("Generics") sought a declaration of non-infringement and revocation......
  • Validity - Annual Patents Review 2017
    • United Kingdom
    • Mondaq UK
    • 19 February 2018
    ...Company Limited & Anr [2017] EWHC 2629 (Pat) (26 October 2017) Arnold J Generics (UK) Ltd v Yeda Research and Development Co Ltd [2013] EWCA Civ 925 Idenix Pharmaceuticals Inc v Gilead Sciences Inc [2016] EWCA Civ 1089 Varian Medical Systems International AG v Elekta Limited & Anr [......
  • Intellectual Property Bulletin - Winter 2013
    • United Kingdom
    • Mondaq United Kingdom
    • 8 January 2014
    ...be used to challenge the validity of a patent. Generics (UK) Ltd (trading as Mylan) v Yeda Research and Development Co Ltd and another [2013] EWCA Civ 925, 29 July The analysis of whether the invention made a technical contribution involved a review of clinical trials data in this case. In ......
  • Using Post-Priority Evidence To Demonstrate Lack Of Invention
    • United Kingdom
    • Mondaq United Kingdom
    • 31 July 2013
    ...Generics [UK] Limited t/a Mylan ("Mylan") v Yeda Research & Development Co Ltd ("Yeda") & Teva Pharmaceuticals Industries Ltd [2013] EWCA Civ 925. It concerns Yeda's patent for a synthetic copolymer known as copolymer-1. Mylan had sought revocation of the patent and a declaration of......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT